It’s a wrap… #AUA24
Loved seeing everyone ❤️

Looking forward to #AUA25
♦️♠️❤️♣️ Dave Penson

Daniel Lin Christopher J. Kane Sam S. Chang MD, MBA Stacy Loeb, MD Brian F. Chapin Todd 〽️ Morgan, MD Marc Dall'Era Sia Daneshmand, M.D. Christian Gratzke Mark Preston james mckiernan

MRI scans may help reduce unnecessary biopsies & diagnose more aggressive cancers.
✅ A meta-analysis of over 80,000 men found MRI led to:
⭕️Fewer biopsies overall (down to 28%)
⭕️Less detection of slow-growing cancers
⭕️Similar detection of high-risk cancers
👉This could mean…

Felipe Couñago PhD presenting the HYPORT-ES trial #ESTRO24
🔸407 pts, 27 Spanish centers
🔸mostly salvage RT 62.5Gy in 25 sessions
🔸very low toxicity rates: GU2+ 12.6% and GI2+ 2%.
🔹 in addition to the RADICALS, NRG-GU0003 is hypo the new SOC?

Updated data from Sunrise1 #TAR200 study presented by Joe Jacob MD, MCR in patients with CIS +/-papillary HR #NMIBC #AUA24
✅ 82.8% Complete Response (CR) rate per central review/86.2% per local assessment
✅ 98% of CRs were achieved within 12 weeks
Johnson & Johnson Innovation #MyCompany #MyTeam

Descansa en paz, Dr. José Pérez Regadera. Un referente de la Oncología radioterápica española. Un día triste y una gran pérdida para SEOR. Nuestro más sentido pésame a la familia, amigos y compañeros.

RADIOSA trial:
🔸oligorecurrent PCa SBRT vs SBRT + 6 mo ADT
🔸 ADT improved bRFS and cRFS
🔸 more polymetastatic recurrences in the ADT arm.
🔹would love to see eugonad-relapse free survival.
🔹 will be interesting to see QoL data and compare with the DART trial
#ESTRO24

Adjuvant pembrolizumab in #UrothelialCarcinoma : #AMBASSADOR study findings. Andrea Apolo, M.D. National Cancer Institute and Sam S. Chang MD, MBA Vanderbilt Urology discuss improved disease-free survival with pembrolizumab versus observation on UroToday. #WatchNow > bit.ly/4ai6FNV

Proud to share the work exploring associations between #Resilience , #PsychologicalResources & #HRQOL and #MentalHealth in patients with bladder cancer UW Urology, led my incredible mentee, Erin Petersen MS2 University of Washington. Thank you Bladder Cancer Advocacy Network for supporting this work! #AUA2024

Novartis enters agreement to acquire Mariana Oncology, strengthening radioligand therapy pipeline | Novartis
😎😎 … the story goes on!!👏👏 ⁦OncoAlert⁩ ⁦UroTarget⁩ ⁦GUARD Consortium⁩ ⁦Advanced Prostate Cancer Consensus Conference⁩ novartis.com/news/media-rel…

GUARD Consortium Ray Manneh Kopp Pablo Maroto Ángel BORQUE FERNANDO Teresa Alonso Gordoa Felipe Couñago PhD Daniel Castellano Javier Puente Enrique Grande Óscar Rodríguez Faba Está genial! No dejéis de leerlo 😊

Study reveals that most patients with advanced urothelial carcinoma in the US🇺🇸do not progress beyond 1⃣st-line treatment

➡️Highlighting the need for more effective and tolerable initial therapies

eIF4F is a thermo-sensing regulatory node in the translational heat shock response dlvr.it/T6LFrp

🔥 📰 Hot of the press: sharing our work on HRR testing for prostate cancer using US database. Most mCRPC still don't get HRR testing. +pts being tested earlier. Race, age, insurance, low socioecon st, outside academia⏩ low testing Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO Rana McKay 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

Big milestone for STAMPEDE2 - our first Site Initiation Visit The Royal Marsden NHS Foundation Trust. Behind the scenes look at how we do these important projects MRC Clinical Trials Unit at UCL The ICR Trials & Tribulations | Oncology Trials Podcast

It's incredible to see so many people raising awareness during #BladderCancerMonth24 ! 🌍🌎 Let's keep the momentum going.

If you haven't joined yet, learn more about our campaign & get involved 👉 ow.ly/FBNC50RmTTq

H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation dlvr.it/T6Kf59

⭐️A goosebumps moment & an example of what an amazing place Gustave Roussy Inserm Prism Center is ? 🇫🇷
⭐️After my keynote lecture this phenomenal person walks up to me.. . “Dr. Subbiah - great talk etc ……. you mentioned BRAF as tissue agnostic target….” Wait for it …‼️
“by…

Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US | Oncology | JAMA Network Open | JAMA Network jamanetwork.com/journals/jaman…

Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial - ScienceDirect sciencedirect.com/science/articl…